These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34121570)

  • 1. Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?
    Wetten A; Jones DEJ; Dyson JK
    Expert Opin Pharmacother; 2021 Oct; 22(15):1949-1953. PubMed ID: 34121570
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
    Levy C
    Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis.
    Lens S
    Gastroenterology; 2024 Aug; 167(3):623-624. PubMed ID: 38387599
    [No Abstract]   [Full Text] [Related]  

  • 4. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New treatment options for primary biliary cholangitis].
    Keitel-Anselmino V; Nitschmann S
    Inn Med (Heidelb); 2024 Sep; 65(9):962-964. PubMed ID: 39167191
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel Treatment Strategies for Primary Biliary Cholangitis.
    Parés A
    Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Treatment Options for Primary Biliary Cholangitis.
    Wong KA; Bahar R; Liu CH; Bowlus CL
    Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of primary biliary cholangitis.
    Laschtowitz A; de Veer RC; Van der Meer AJ; Schramm C
    United European Gastroenterol J; 2020 Jul; 8(6):667-674. PubMed ID: 32299307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratified medicine and primary biliary cholangitis.
    Mells GF; Jones DE
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):319-321. PubMed ID: 28397694
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease-modifying therapies and symptomatic management for primary biliary cholangitis.
    Patel R; Portone G; Lambert JA; Mak S; Alrubaiy L
    Br J Hosp Med (Lond); 2021 Nov; 82(11):1-9. PubMed ID: 34817254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies.
    Liu CH; Bowlus CL
    Clin Liver Dis; 2022 Nov; 26(4):705-726. PubMed ID: 36270725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old and new treatments for primary biliary cholangitis.
    Chascsa D; Carey EJ; Lindor KD
    Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and potential treatments for primary biliary cholangitis.
    Shah RA; Kowdley KV
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):306-315. PubMed ID: 31806572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation.
    Quigley G; Al Ani M; Nadir A
    Dig Dis Sci; 2018 Feb; 63(2):529-532. PubMed ID: 29305737
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment.
    MacDonald N; Loh R; Fenkel JM; Sass DA; Halegoua-DeMarzio D
    BMC Gastroenterol; 2024 Jan; 24(1):18. PubMed ID: 38178006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
    Schattenberg JM
    Gut; 2020 Aug; 69(8):1377-1378. PubMed ID: 32205421
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
    Yuan Z; Jia G; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
    Liu BD; Qureshi K
    Dig Dis Sci; 2023 Feb; 68(2):346-348. PubMed ID: 36098875
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary Biliary Cholangitis-associated Palmar Keratosis.
    Usami J
    Intern Med; 2021 Sep; 60(17):2877. PubMed ID: 33746168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.